Nuveen Asset Management, LLC Repligen Corp Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 538,430 shares of RGEN stock, worth $80.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

538,430

Previous 541,117 0.5%

Holding current value

$80.3 Million

Previous $97.3 Million 1.78%

% of portfolio

0.03%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$170.78 - $208.42 $458,885 - $560,024	-2,687 Reduced 0.5%	538,430 $99 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $19.1 Million - $31 Million	166,998 Added 44.64%	541,117 $97.3 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $22.2 Million - $28.2 Million	159,984 Added 74.71%	374,119 $59.5 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $1.36 Million - $1.77 Million	9,825 Added 4.81%	214,135 $30.3 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $1.68 Million - $2.16 Million	-10,915 Reduced 5.07%	204,310 $34.4 Million

Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $8.1 Million - $11 Million	-49,876 Reduced 18.81%	215,225 $36.4 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $1.61 Million - $2.58 Million	-10,061 Reduced 3.66%	265,101 $49.6 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $1.4 Million - $1.87 Million	-9,949 Reduced 3.49%	275,162 $44.7 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $10.1 Million - $16.2 Million	62,727 Added 28.21%	285,111 $53.6 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $6.55 Million - $8.05 Million	-26,444 Reduced 10.63%	222,384 $58.9 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $9.26 Million - $15.4 Million	-47,568 Reduced 16.05%	248,828 $71.9 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $166,533 - $221,833	-1,004 Reduced 0.34%	296,396 $59.2 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $914,295 - $1.15 Million	-5,069 Reduced 1.68%	297,400 $57.8 Million
Q4 2020 May 17, 2021	SELL	$148.08 - $206.57 $1.83 Million - $2.56 Million	-12,390 Reduced 3.94%	302,469 $58 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $12.3 Million - $17.1 Million	82,748 Added 35.65%	314,859 $60.3 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $6.61 Million - $8.54 Million	53,947 Added 30.28%	232,111 $34.2 Million
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $22.4 Million - $33.3 Million	-236,990 Reduced 57.08%	178,164 $22 Million
Q1 2020 May 14, 2020	BUY	$84.96 - $109.14 $2.07 Million - $2.65 Million	24,310 Added 6.22%	415,154 $40.1 Million
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $6.22 Million - $7.84 Million	84,232 Added 27.47%	390,844 $36.2 Million
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $4.28 Million - $5.33 Million	-55,796 Reduced 15.4%	306,612 $23.5 Million
Q2 2019 Aug 15, 2019	BUY	$54.2 - $85.95 $18.1 Million - $28.8 Million	334,696 Added 1207.77%	362,408 $31.1 Million
Q1 2019 May 14, 2019	SELL	$49.45 - $62.8 $192,657 - $244,668	-3,896 Reduced 12.33%	27,712 $1.64 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $949,805 - $1.36 Million	-19,681 Reduced 38.37%	31,608 $1.67 Million
Q3 2018 Nov 13, 2018	SELL	$46.8 - $58.97 $412,635 - $519,938	-8,817 Reduced 14.67%	51,289 $2.84 Million
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $1.37 Million - $1.83 Million	38,860 Added 182.91%	60,106 $2.83 Million
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $103,868 - $124,271	3,193 Added 17.69%	21,246 $0
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $667,599 - $831,521	18,053	18,053 $692,000

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.27B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Repligen Corp Transaction History